« Previous article
Bioperfectus Rapid T...

8th February 2021  Product update: rapidvirology staff writer

Rapid IgM/IgG Antibody Test Vital for COVID-19 Vaccination Program


The function of antibody testing is to identify people who have been infected with the virus; which will play an important role in determining priority groups in a vaccination program.

The Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit from Bioperfectus is an in vitro diagnostic test used for the detection of novel coronavirus (SARS-CoV-2) IgM and IgG antibodies.

This product is based on immunochromatographic technology. The detection area of the strip has an IgM test line (T2 line), an IgG test line (T1 line) and a control line (C line).

Advantages:

  • Fast results within 10-15 minutes
  • Easy to use: 3 steps to finish the test
  • Quality control: ensure the result is reliable
  • Multiple antibody tests identify the stage of infection
 
Parameters:
 
Target Region
IgM/IgG
Clinical Sensitivity
82.4% (IgM), 91.2% (IgG)
Clinical Specificity
99.2% (IgM), 96.4% (IgG)
Sample Type
Human Whole Blood, Serum, Plasma
Storage Temperature
4 - 30oC
Transportation Temperature
-20 - 45oC
 

Catalog Number: SC30201W
Product Name: Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit
Packaging: 20 Tests/Box
Certificates: CE-IVD, Registration in Russia.

To learn more, please click here, or use the Request Information button provided below.


    

Tags:

Date Published: 8th February 2021

Source article link: View

Note: This content has been edited by a rapidvirology.com staff writer for style and content.


View full company details


Related news